JRCT ID: jRCT2080220414
Registered date:13/07/2007
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Pain due to osteoporosis |
Date of first enrollment | 13/07/2007 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : OPC-249 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Inhalation |
Outcome(s)
Primary Outcome | Efficacy, safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 46age old |
---|---|
Age maximum | <= 79age old |
Gender | Female |
Include criteria | Patients who fulfill all of the following items -Patients with primary osteoporosis -Patients who have existing 1-4 vertebral fractures -Patients with back pain persisting for one week or more -Postmenopausal women between 46 and less than 80 years of age |
Exclude criteria |
Related Information
Primary Sponsor | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-070423 |
Contact
Public contact | |
Name | |
Address | 03-6361-7314 |
Telephone | |
Affiliation | Otsuka Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |